58 results
S-8
EX-99.3
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
be approved by the Company’s independent compensation committee or a majority of the Company’s independent directors (as defined in Nasdaq Stock Market Rule … of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event
8-K
EX-1.1
afogd0
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
0nb5i khtbshmp2pav
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
b4i5vn
28 Nov 23
Prospectus supplement for primary offering
4:25pm
S-3ASR
EX-4.7
an2i3q6vwfiaakuyy
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
s6l12gfod62g40x2o5u
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.4
tloka
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.6
akbco
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
3c7xi 2x0znbnh45z
23 Sep 22
Automatic shelf registration
4:08pm
8-K
EX-1.1
1walgcdb
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
vucxh6fd kbd
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
85j1wt9kt5qxzpb
20 Jul 22
Prospectus supplement for primary offering
4:22pm